Skip to main content
Results: 3โ€“4 weeks Sample: Whole Blood (Peripheral) or Extracted DNA or Dried Blood Spot

Test Price

2,800 AED

โœ… Home Collection Available

๐Ÿ“‹ Results in 3โ€“4 weeks

PEX19 Gene Zellweger Syndrome Genetic Test (NGS) โ€“ 2,800 AED

Executive Summary & Core Metrics

  • Premium Logistics: VIP mobile phlebotomy daily 7 AM โ€“ 11 PM with temperature-controlled cold-chain transport.
  • Clinical Guidance: Post-test telephonic consultation with a board-certified clinical geneticist.
  • Insurance: Direct insurance verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The PEX19 Gene Zellweger Syndrome Genetic Test is a comprehensive next-generation sequencing analysis that identifies disease-causing variants in the PEX19 gene, responsible for Zellweger spectrum disordersโ€”a lethal peroxisomal biogenesis disorder. This precise genetic analysis enables early diagnosis for newborns presenting with severe neurological delay and congenital anomalies.

Feature Our Test (ISO 9001:2015) Closest Alternative
Methodology Full gene coding region + splice sites by NGS, confirmed by Sanger Selected exons only, may miss deep intronic variants
Turnaround Speed 3โ€“4 weeks, with expedited VIP phlebotomy available 7AM-11PM 6โ€“8 weeks via overseas send-out

Physician Insight & Safety Protocols

From the Desk of Dr. Lina Osama Zaki Quteineh (DHA: 9294403), Consultant Medical Genetics: A positive PEX19 variant must be interpreted in the context of the patientโ€™s clinical and biochemical profile, as some genotypes may present with milder phenotypes. I strongly urge families to discuss all results with a clinical geneticist before making any life-changing decisions; this test is not a standalone diagnostic tool but part of a comprehensive neurometabolic workup.

โš  Medication Warning

Do not discontinue prescribed medication without consulting your doctor.

Exclusion Criteria & Emergency Red Flags

  • Patients with acute metabolic decompensation or unstable clinical status should not undergo elective blood draw.
  • Inadequate informed consent or absence of a legal guardian for minors (per Federal Decree-Law No. 4 of 2016 on Medical Liability).
  • If the patient experiences sudden worsening of seizures, apnea, or severe hypotonia, seek immediate emergency care and delay the test.
  • Genetic counseling is mandatory prior to sample collection; failure to complete counseling voids test validity under UAE medical liability law (Federal Decree-Law No. 4 of 2016).

Patient FAQ & Clinical Guidance

1. What does the PEX19 Genetic Test detect and who needs it?

Quick answer: This test identifies genetic mutations in the PEX19 gene causing Zellweger spectrum disorder, a severe peroxisomal disease, and is critical for infants with unexplained hypotonia, seizures, or craniofacial dysmorphism.

It is also used for carrier screening in families with a known mutation and for prenatal diagnosis when indicated. Testing requires a genetic counseling session to evaluate pedigree and consent, in compliance with UAE PDPL.

2. How is the test performed and what sample is required?

Quick answer: A small amount of whole blood, extracted DNA, or a dried blood spot on an FTA card is collected during a hospital-grade home visit, then sent via cold-chain logistics to our ISO-certified genomics laboratory.

Our VIP mobile phlebotomy service operates daily from 7 AM to 11 PM, ensuring minimal discomfort. The sample is processed using Next-Generation Sequencing with full gene coverage, followed by confirmatory Sanger sequencing of all pathogenic variants.

3. What do the results mean and how quickly will I receive them?

Quick answer: Results are typically reported within 3 to 4 weeks and include a clear classification of any variant as pathogenic, likely pathogenic, or benign, accompanied by a clinical interpretation guide.

A negative result does not exclude the disease if clinical suspicion remains high; additional biochemical testing may be necessary. A post-test telephonic consultation with a clinical geneticist is included to explain the implications for the patient and family.

4. Is genetic counseling required before and after the test?

Quick answer: Yes, genetic counseling is mandatory before sample collection to ensure informed consent and after results to discuss implications. This complies with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.

UAE Regulatory & Data Privacy Adherence

This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient genetic data is encrypted, anonymized, and stored on secure servers within the UAE.

Clinical & Logistical Metadata

Test Name PEX19 Gene Zellweger Syndrome Genetic Test (NGS)
Price (AED) 2,800 AED
Turnaround Time 3โ€“4 weeks
Sample Type / Matrix Whole Blood (Peripheral) or Extracted DNA
Methodology Used Next-Generation Sequencing (NGS) with Sanger confirmation
ICD-10-CM Code E71.510
LOINC Code 62869-5
DHA Facility License & Address DHA License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ู†ุง ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

Preparation Required

["Genetic counseling is mandatory prior to sample collection."]

D

Medically Reviewed by Dr. Lina Osama Zaki Quteineh

All content reviewed by qualified professionals for accuracy.

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO 9001:2015 Certified

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians